Arax Advisory Partners’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.58K | Hold |
600
| – | – | ﹤0.01% | 2642 |
|
|
2025
Q1 | $1.81K | Hold |
600
| – | – | ﹤0.01% | 2099 |
|
|
2024
Q4 | $1.54K | Sell |
600
-8
| -1% | -$20 | ﹤0.01% | 2070 |
|
|
2024
Q3 | $2.26K | Sell |
608
-236
| -28% | -$878 | ﹤0.01% | 2025 |
|
|
2024
Q2 | $5.34K | Buy |
844
+244
| +41% | +$1.54K | ﹤0.01% | 1569 |
|
|
2024
Q1 | $3.22K | Hold |
600
| – | – | ﹤0.01% | 974 |
|
|
2023
Q4 | $3.01K | Hold |
600
| – | – | ﹤0.01% | 967 |
|
|
2023
Q3 | $1.01K | Hold |
600
| – | – | ﹤0.01% | 1122 |
|
|
2023
Q2 | $1.67K | Hold |
600
| – | – | ﹤0.01% | 1030 |
|
|
2023
Q1 | $1.09K | Hold |
600
| – | – | ﹤0.01% | 1088 |
|
|
2022
Q4 | $3.04K | Hold |
600
| – | – | ﹤0.01% | 895 |
|
|
2022
Q3 | $3K | Hold |
600
| – | – | ﹤0.01% | 907 |
|
|
2022
Q2 | $2K | Hold |
600
| – | – | ﹤0.01% | 949 |
|
|
2022
Q1 | $3K | Hold |
600
| – | – | ﹤0.01% | 883 |
|
|
2021
Q4 | $4K | Hold |
600
| – | – | ﹤0.01% | 804 |
|
|
2021
Q3 | $6K | Buy |
+600
| New | +$6K | ﹤0.01% | 732 |
|